The projected average peak sales per new asset increased from *** million U.S. dollars in 2017 to *** million U.S. dollars in 2023. The latest year, however, showed a recovery up to *** million U.S. dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Deloitte. (March 24, 2026). Projected average peak sales for each new biopharmaceutical asset from 2013 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte. "Projected average peak sales for each new biopharmaceutical asset from 2013 to 2025 (in million U.S. dollars)." Chart. March 24, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte. (2026). Projected average peak sales for each new biopharmaceutical asset from 2013 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte. "Projected Average Peak Sales for Each New Biopharmaceutical Asset from 2013 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 24 Mar 2026, /statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte, Projected average peak sales for each new biopharmaceutical asset from 2013 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/825738/peak-sales-for-each-pharmaceutical-asset/ (last visited July 23, 2026)
Projected average peak sales for each new biopharmaceutical asset from 2013 to 2025 (in million U.S. dollars) [Graph], Deloitte, March 24, 2026. [Online]. Available: /statistics/825738/peak-sales-for-each-pharmaceutical-asset/
